Clinical Trial

Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer

Study acronym: RECTUM2015
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 18, 2022 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Phase II, Multicenter, Open-label, Randomized Study evaluating neoadjuvant chemotherapy (FOLFOX4) in patients with stage II and III colorectal cancer with standard chemoradiation Defined by Magnetic Resonance Imaging
Trial Details
NCT Number NCT05378919
Lead Sponsor Lithuanian University of Health Sciences
Conditions Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
Enrollment 250 participants
Start Date 2015-06-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2022-05-18